MDA-9/syntenin: a positive gatekeeper of melanoma metastasis
- PMID: 22201728
- DOI: 10.2741/3911
MDA-9/syntenin: a positive gatekeeper of melanoma metastasis
Abstract
Melanoma differentiation associated gene-9 (MDA-9), synonymous with syntenin, is an adapter protein that provides a central role in regulating cell-cell and cell-matrix adhesion. MDA-9/syntenin transduces signals from the cell-surface to the interior through its interaction with a plethora of additional proteins and actively participates in intracellular trafficking and cell-surface targeting, synaptic transmission, and axonal outgrowth. Recent studies demarcate a seminal role of MDA-9/syntenin in cancer metastasis. In the context of melanoma, MDA-9/syntenin functions as a positive regulator of melanoma progression and metastasis through interactions with c-Src and promotes the formation of an active FAK/c-Src signaling complex leading to NF-k B and matrix metalloproteinase (MMP) activation. The present review provides a current perspective of our understanding of the important features of MDA-9/syntenin and its significant role in tumor cell metastasis with special focus on molecular mechanism of action.
Similar articles
-
RETRACTED: mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.Cancer Res. 2007 Feb 15;67(4):1812-22. doi: 10.1158/0008-5472.CAN-06-3875. Cancer Res. 2007. Retraction in: Cancer Res. 2024 Oct 1;84(19):3312. doi: 10.1158/0008-5472.CAN-24-2216. PMID: 17308124 Retracted.
-
mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15914-9. doi: 10.1073/pnas.0808171105. Epub 2008 Oct 2. Proc Natl Acad Sci U S A. 2008. PMID: 18832467 Free PMC article.
-
MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.J Biol Chem. 2015 Feb 6;290(6):3333-48. doi: 10.1074/jbc.M114.606913. Epub 2014 Dec 10. J Biol Chem. 2015. Retraction in: J Biol Chem. 2015 Oct 23;290(43):25847. doi: 10.1074/jbc.A114.606913. PMID: 25505176 Free PMC article. Retracted.
-
mda-9/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis.Cancer Res. 2008 May 1;68(9):3087-93. doi: 10.1158/0008-5472.CAN-07-6210. Cancer Res. 2008. PMID: 18451132 Review.
-
mda-9/syntenin: recent insights into a novel cell signaling and metastasis-associated gene.Pharmacol Ther. 2004 Nov;104(2):101-15. doi: 10.1016/j.pharmthera.2004.08.004. Pharmacol Ther. 2004. PMID: 15518882 Review.
Cited by
-
Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin.Oncogene. 2019 Oct;38(41):6781-6793. doi: 10.1038/s41388-019-0920-5. Epub 2019 Aug 12. Oncogene. 2019. PMID: 31406249 Free PMC article.
-
Application of Artificial Intelligence in Discovery and Development of Anticancer and Antidiabetic Therapeutic Agents.Evid Based Complement Alternat Med. 2022 Apr 25;2022:6201067. doi: 10.1155/2022/6201067. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Aug 9;2023:9782318. doi: 10.1155/2023/9782318. PMID: 35509623 Free PMC article. Retracted. Review.
-
Reply to Yoshida: Delineating critical roles of MDA-9 in protective autophagy-mediated anoikis resistance in human glioma stem cells.Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7654-E7655. doi: 10.1073/pnas.1811113115. Epub 2018 Aug 7. Proc Natl Acad Sci U S A. 2018. PMID: 30087190 Free PMC article. No abstract available.
-
MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.Pharmacol Res. 2020 May;155:104695. doi: 10.1016/j.phrs.2020.104695. Epub 2020 Feb 13. Pharmacol Res. 2020. PMID: 32061839 Free PMC article. Review.
-
Syndecan binding protein (SDCBP) is overexpressed in estrogen receptor negative breast cancers, and is a potential promoter for tumor proliferation.PLoS One. 2013;8(3):e60046. doi: 10.1371/journal.pone.0060046. Epub 2013 Mar 22. PLoS One. 2013. PMID: 23533663 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous